Purification and partial characterization of a bacteriocin produced by Eikenella corrodens
- PMID: 17922820
- DOI: 10.1111/j.1365-2672.2007.03565.x
Purification and partial characterization of a bacteriocin produced by Eikenella corrodens
Abstract
Aims: The purpose of this study was to purify and characterize a bacteriocin produced by Eikenella corrodens A32E2.
Methods and results: Peptostreptococcus anaerobius ATCC27337 was used as indicator strain in antagonistic assays for bacteriocin-producing E. corrodens A32E2. Protein extraction was influenced by pH and buffer composition. The protein was active in the pH range 6-8. Inhibitory activity was lost by both heating and treatment with proteolytic enzymes and decreased with organic solvents. The substance is rather unstable but maintains 100% of its activity after being exposed to acetone and when stored at -70 degrees C. The antagonistic substance was first precipitated by ammonium sulfate and further partially purified by Mono-Q FPLC and C-18 HPLC. Mass spectrometry analysis showed that the molecular mass was 23 625 Da, and the sequence obtained for the N-terminus was: Met-Asn-Phe-Asp-Glu-Lys-Val-Gly-Lys-Val-X-Phe-Lys-Val-Gly-Asp.
Conclusions: The evidence presented in this study supports the idea that an antagonistic substance produced by E. corrodens A32E2 isolated from a periodontal diseased site is a novel bacteriocin, which we designate corrodecin.
Significance and impact of the study: We anticipated that corrodecin might play an important role at the periodontal site. This compound could also be attractive in biotechnological applications as an interesting tool for oral ecosystem control.
Similar articles
-
Production of antagonistic substance by Eikenella corrodens isolated from the oral cavity of human beings with and without periodontal disease.J Appl Microbiol. 2007 Jul;103(1):245-51. doi: 10.1111/j.1365-2672.2006.03211.x. J Appl Microbiol. 2007. PMID: 17584471
-
Purification and partial characterization of a bacteriocin produced by an oral Fusobacterium nucleatum isolate.J Appl Microbiol. 2009 Aug;107(2):699-705. doi: 10.1111/j.1365-2672.2009.04250.x. Epub 2009 Apr 23. J Appl Microbiol. 2009. PMID: 19426276
-
Further characterization of a bacteriocin produced by Lactobacillus paracasei HL32.J Appl Microbiol. 2009 Jun;106(6):1928-40. doi: 10.1111/j.1365-2672.2009.04146.x. Epub 2009 Feb 25. J Appl Microbiol. 2009. PMID: 19245409
-
Purification, amino acid sequence and characterization of Bacthuricin F4, a new bacteriocin produced by Bacillus thuringiensis.J Appl Microbiol. 2005;98(4):881-8. doi: 10.1111/j.1365-2672.2004.02513.x. J Appl Microbiol. 2005. PMID: 15752334
-
[Infectious spondylodiscitis by Eikenella corrodens].Enferm Infecc Microbiol Clin. 1999 Oct;17(8):419-20. Enferm Infecc Microbiol Clin. 1999. PMID: 10563097 Review. Spanish. No abstract available.
Cited by
-
Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients.NPJ Biofilms Microbiomes. 2016 Dec 19;2:7. doi: 10.1038/s41522-016-0009-7. eCollection 2016. NPJ Biofilms Microbiomes. 2016. PMID: 28649401 Free PMC article.
-
Purification and partial characterization of bacteriocin produced by Lactococcus lactis ssp. lactis LL171.World J Microbiol Biotechnol. 2012 Apr;28(4):1647-55. doi: 10.1007/s11274-011-0971-4. Epub 2011 Dec 10. World J Microbiol Biotechnol. 2012. PMID: 22805947
-
Characterization of a potential ABC-type bacteriocin exporter protein from Treponema denticola.BMC Oral Health. 2016 Jul 16;17(1):18. doi: 10.1186/s12903-016-0243-7. BMC Oral Health. 2016. PMID: 27422166 Free PMC article.
-
Characterization of clustered bacteriocin-type signal domain protein genes in Treponema denticola.Front Dent Med. 2025 Feb 19;6:1543535. doi: 10.3389/fdmed.2025.1543535. eCollection 2025. Front Dent Med. 2025. PMID: 40045935 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous